piperazine has been researched along with Acute Confusional Senile Dementia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 8 (61.54) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, YP | 1 |
| Shankar, G | 1 |
| Jahan, S | 1 |
| Singh, G | 1 |
| Kumar, N | 1 |
| Barik, A | 1 |
| Upadhyay, P | 1 |
| Singh, L | 1 |
| Kamble, K | 1 |
| Singh, GK | 1 |
| Tiwari, S | 1 |
| Garg, P | 1 |
| Gupta, S | 1 |
| Modi, G | 1 |
| Falkenstein, M | 1 |
| Reiner-Link, D | 1 |
| Zivkovic, A | 1 |
| Gering, I | 1 |
| Willbold, D | 1 |
| Stark, H | 1 |
| Li, Z | 1 |
| Meng, X | 1 |
| Ma, G | 1 |
| Liu, W | 1 |
| Li, W | 1 |
| Cai, Q | 1 |
| Wang, S | 1 |
| Huang, G | 1 |
| Zhang, Y | 1 |
| Chaves, S | 1 |
| Resta, S | 1 |
| Rinaldo, F | 1 |
| Costa, M | 1 |
| Josselin, R | 1 |
| Gwizdala, K | 1 |
| Piemontese, L | 1 |
| Capriati, V | 1 |
| Pereira-Santos, AR | 1 |
| Cardoso, SM | 1 |
| Santos, MA | 1 |
| Jia, J | 1 |
| Zhang, L | 2 |
| Song, J | 1 |
| Dai, J | 1 |
| Cui, M | 1 |
| Boutin, S | 1 |
| Maltais, R | 1 |
| Roy, J | 1 |
| Poirier, D | 1 |
| Mathew, B | 1 |
| Oh, JM | 1 |
| Baty, RS | 1 |
| Batiha, GE | 1 |
| Parambi, DGT | 1 |
| Gambacorta, N | 1 |
| Nicolotti, O | 1 |
| Kim, H | 1 |
| Makhaeva, GF | 1 |
| Lushchekina, SV | 1 |
| Kovaleva, NV | 1 |
| Yu Astakhova, T | 1 |
| Boltneva, NP | 1 |
| Rudakova, EV | 1 |
| Serebryakova, OG | 1 |
| Proshin, AN | 1 |
| Serkov, IV | 1 |
| Trofimova, TP | 1 |
| Tafeenko, VA | 1 |
| Radchenko, EV | 1 |
| Palyulin, VA | 1 |
| Fisenko, VP | 1 |
| Korábečný, J | 1 |
| Soukup, O | 1 |
| Richardson, RJ | 1 |
| He, L | 1 |
| Boice, A | 1 |
| Liu, K | 1 |
| Yan, X | 1 |
| Jiang, Y | 1 |
| Zhang, S | 1 |
| Nazari, M | 1 |
| Tabatabai, SA | 1 |
| Rezaee, E | 1 |
| Cumming, J | 1 |
| Babu, S | 1 |
| Huang, Y | 1 |
| Carrol, C | 1 |
| Chen, X | 1 |
| Favreau, L | 1 |
| Greenlee, W | 1 |
| Guo, T | 1 |
| Kennedy, M | 1 |
| Kuvelkar, R | 1 |
| Le, T | 1 |
| Li, G | 1 |
| McHugh, N | 1 |
| Orth, P | 1 |
| Ozgur, L | 1 |
| Parker, E | 1 |
| Saionz, K | 1 |
| Stamford, A | 1 |
| Strickland, C | 1 |
| Tadesse, D | 1 |
| Voigt, J | 1 |
| Zhang, Q | 1 |
| Hamulakova, S | 1 |
| Janovec, L | 1 |
| Hrabinova, M | 1 |
| Kristian, P | 1 |
| Kuca, K | 1 |
| Banasova, M | 1 |
| Imrich, J | 1 |
| McConnell, RM | 1 |
| Green, AW | 1 |
| Trana, CJ | 1 |
| McConnell, MS | 1 |
| Lindley, JF | 1 |
| Sayyar, K | 1 |
| Godwin, WE | 1 |
| Hatfield, SE | 1 |
13 other studies available for piperazine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Biological Products; Biphenyl Compou | 2021 |
Histamine H
Topics: Alzheimer Disease; Amyloid beta-Peptides; Dose-Response Relationship, Drug; Histamine H3 Antagonists | 2021 |
Increasing brain glucose metabolism by ligustrazine piperazine ameliorates cognitive deficits through PPARγ-dependent enhancement of mitophagy in APP/PS1 mice.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; An | 2022 |
Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Chelating Agents; Chol | 2020 |
Discovery of Diphenoxy Derivatives with Flexible Linkers as Ligands for β-Amyloid Plaques.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Autoradiography; Brain; Humans; Iodine Radioisoto | 2020 |
Synthesis of 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: Selectivity, metabolic stability and enhanced potency.
Topics: 17-Hydroxysteroid Dehydrogenases; Alzheimer Disease; Biocatalysis; Drug Evaluation, Preclinical; Enz | 2021 |
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders.
Topics: Alzheimer Disease; Chalcones; Cholinesterase Inhibitors; Humans; Kinetics; Molecular Docking Simulat | 2021 |
Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Topics: Acetylcholinesterase; Alzheimer Disease; Aminoquinolines; Animals; Antioxidants; Benzothiazoles; But | 2021 |
Design and characterization of bivalent compounds as potential neuroprotectants for Alzheimer's disease: Impact of the spacer on biological activity.
Topics: Alzheimer Disease; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Structure; Neuro | 2018 |
2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Humans; Models, Molecular; Molec | 2018 |
Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Ac | 2010 |
Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Chemistry Techniques, Synthetic; Cho | 2012 |
New cathepsin d inhibitors with hydroxyethylamine isosteres: preparation and characterization.
Topics: Alzheimer Disease; Antineoplastic Agents; Aspartic Acid Endopeptidases; Carboxylic Acids; Cathepsin | 2006 |